Medical Device Network on MSN

AliveCor secures FDA approval for next-generation Kardia 12L ECG system

The newly cleared features include three rhythm modifiers and two axis-related morphology determinations: RAD and LAD.

AliveCor Announces FDA Clearance of New Cardiac Determinations for Kardia 12L ECG System, Bringing Total to 39

AliveCor, the global leader in AI-powered cardiology, today announced it has received U.S. Food and Drug Administration (FDA) clearance for the next generation of KAI 12L--the AI powering the Kardia ...